NO20040066L - Nye antikonvulsivaderivater - Google Patents

Nye antikonvulsivaderivater

Info

Publication number
NO20040066L
NO20040066L NO20040066A NO20040066A NO20040066L NO 20040066 L NO20040066 L NO 20040066L NO 20040066 A NO20040066 A NO 20040066A NO 20040066 A NO20040066 A NO 20040066A NO 20040066 L NO20040066 L NO 20040066L
Authority
NO
Norway
Prior art keywords
anticonvulsant derivatives
new anticonvulsant
new
derivatives
anticonvulsant
Prior art date
Application number
NO20040066A
Other languages
English (en)
Norwegian (no)
Inventor
Cynthia Maryanoff
Ahmed F Abdel-Magid
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23174444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20040066(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20040066L publication Critical patent/NO20040066L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
NO20040066A 2001-07-09 2004-01-08 Nye antikonvulsivaderivater NO20040066L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30396201P 2001-07-09 2001-07-09
PCT/US2002/021016 WO2003006467A1 (en) 2001-07-09 2002-07-03 Novel anticonvulsant derivative salts

Publications (1)

Publication Number Publication Date
NO20040066L true NO20040066L (no) 2004-03-01

Family

ID=23174444

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040066A NO20040066L (no) 2001-07-09 2004-01-08 Nye antikonvulsivaderivater

Country Status (27)

Country Link
US (2) US7098188B2 (da)
EP (1) EP1414824B1 (da)
JP (1) JP2005502629A (da)
KR (1) KR20040013127A (da)
CN (1) CN1288159C (da)
AR (1) AR036137A1 (da)
AT (1) ATE361304T1 (da)
AU (1) AU2002346042B2 (da)
BR (1) BR0211063A (da)
CA (1) CA2452612A1 (da)
DE (1) DE60219922T2 (da)
DK (1) DK1414824T3 (da)
ES (1) ES2284884T3 (da)
HK (1) HK1064094A1 (da)
HR (1) HRP20040017A2 (da)
HU (1) HUP0401080A2 (da)
IL (2) IL159698A0 (da)
MX (1) MXPA04000232A (da)
NO (1) NO20040066L (da)
NZ (1) NZ530507A (da)
PL (1) PL367635A1 (da)
PT (1) PT1414824E (da)
RU (1) RU2320665C2 (da)
SI (1) SI21370A (da)
UA (1) UA78211C2 (da)
WO (1) WO2003006467A1 (da)
ZA (1) ZA200400970B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US7041650B2 (en) 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
US20030092636A1 (en) * 2001-11-06 2003-05-15 Silberstein Stephen D. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US6559293B1 (en) * 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate
US20030224006A1 (en) 2002-03-01 2003-12-04 Zaworotko Michael J. Multiple-component solid phases containing at least one active pharmaceutical ingredient
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US20090088443A1 (en) * 2002-02-15 2009-04-02 Julius Remenar Novel crystalline forms of conazoles and methods of making and using the same
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
JP2006500377A (ja) * 2002-06-21 2006-01-05 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 改善された溶解性を有する医薬組成物
US8183290B2 (en) * 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US7638291B2 (en) * 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
US20060088886A1 (en) * 2004-10-25 2006-04-27 Anlong Ouyang Topiramate analogs
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9489372B2 (en) * 2013-03-15 2016-11-08 Apple Inc. Web-based spell checker
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
TWI826531B (zh) 2018-09-21 2023-12-21 南韓商愛思開生物製藥股份有限公司 具有㗁二唑之化合物及包含該化合物之醫藥組合物
US20210169844A1 (en) 2019-12-10 2021-06-10 Tulex Pharmaceuticals Inc. Compositions and methods for treating epilepsy, seizures and other conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
AU651244B2 (en) * 1991-09-19 1994-07-14 Mcneilab, Inc. Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5384327A (en) 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
US5952187A (en) * 1995-12-01 1999-09-14 Oxis International, Inc. Topiramate immunoassay
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
DK1158973T3 (da) 1999-02-24 2005-05-30 Univ Cincinnati Anvendelse af sulfamatderivater til behandling af impulskontrolafvigelser
UA78211C2 (en) 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
US6559293B1 (en) 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate

Also Published As

Publication number Publication date
US20060105966A1 (en) 2006-05-18
DE60219922D1 (de) 2007-06-14
US7098188B2 (en) 2006-08-29
AR036137A1 (es) 2004-08-11
RU2320665C2 (ru) 2008-03-27
AU2002346042B8 (en) 2003-01-29
DE60219922T2 (de) 2008-01-17
HK1064094A1 (en) 2005-01-21
AU2002346042B2 (en) 2007-10-18
RU2004100274A (ru) 2005-06-20
NZ530507A (en) 2007-01-26
HRP20040017A2 (en) 2004-10-31
ES2284884T3 (es) 2007-11-16
EP1414824B1 (en) 2007-05-02
UA78211C2 (en) 2007-03-15
IL159698A0 (en) 2004-06-20
WO2003006467A1 (en) 2003-01-23
EP1414824A1 (en) 2004-05-06
HUP0401080A2 (hu) 2004-09-28
SI21370A (sl) 2004-06-30
JP2005502629A (ja) 2005-01-27
DK1414824T3 (da) 2007-07-16
PT1414824E (pt) 2007-06-27
PL367635A1 (en) 2005-03-07
CN1551882A (zh) 2004-12-01
ATE361304T1 (de) 2007-05-15
CN1288159C (zh) 2006-12-06
US20030069190A1 (en) 2003-04-10
BR0211063A (pt) 2004-07-20
ZA200400970B (en) 2005-02-07
CA2452612A1 (en) 2003-01-23
KR20040013127A (ko) 2004-02-11
IL159698A (en) 2009-09-22
MXPA04000232A (es) 2005-03-07

Similar Documents

Publication Publication Date Title
NO20035428D0 (no) Nye anti-ineffektiver
NO20034992D0 (no) Nye 4-aninlinokinolin-3-karboksamider
NO20040014L (no) Nye forbindelser
NO20041003L (no) Nye forbindelser
NO20034970D0 (no) Nye arylheteroalkylaminderivater
NO20034665D0 (no) Nye forbindelser
ATE319451T1 (de) Tetrahydrochinolin-derivate
NO20026064L (no) Nye forbindelser
NO20023932L (no) Nye forbindelser
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
DE60227853D1 (de) Substituierte Pyridinylamine
NO20034308L (no) Nye tyrokinase-inhibitorer
NO20035634D0 (no) Diamin-derivater
DE50206892D1 (de) Substituierte imidazotriazinone
NO20040066L (no) Nye antikonvulsivaderivater
NO20025151D0 (no) Nye forbindelser
NO20031141D0 (no) Nye forbindelser
EE200300447A (et) Asendatud bensofuraan-2-karboksamiidide derivaadid
NO20026162D0 (no) Nye forbindelser
NO20041185L (no) Nye sykloheksylsulfoner
DK1373228T3 (da) Substituerede fluoralkoxyphenylsulfonylurinstoffer
IS2523B (is) Turn vindorkuvers
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
NO20030274D0 (no) Nye aryleten-sulfonamider
NO20026081D0 (no) Nye forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application